S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis. This evidence concerns the gene S100A9 and metabolic dysfunction-associated steatohepatitis.